[Treatment of otorhinolaryngological infections with minocycline].
D000293:Adolescent; D000328:Adult; D002509:Cephaloridine / Q000494:pharmacology; D002648:Child; D002701:Chloramphenicol / Q000494:pharmacology; D004917:Erythromycin / Q000494:pharmacology; D005260:Female; D005667:Furunculosis / Q000188:drug therapy; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010033:Otitis Media / Q000188:drug therapy; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy*; D010400:Penicillin G / Q000494:pharmacology; D012852:Sinusitis / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013307:Streptomycin / Q000494:pharmacology; D013752:Tetracycline / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014069:Tonsillitis / Q000188:drug therapy
D004917:Erythromycin; D002701:Chloramphenicol; D013752:Tetracycline; D002509:Cephaloridine; D010400:Penicillin G; D013307:Streptomycin